Spending on research into neglected disease reached record high in 2017BMJ 2019; 364 doi: https://doi.org/10.1136/bmj.l303 (Published 24 January 2019) Cite this as: BMJ 2019;364:l303
- Jacqui Wise
- London, UK
The UK has increased its spending on research and development (R&D) into neglected diseases more than any other country, according to a new report.1
The 11th annual G-Finder report says that global funding for basic research and product development for neglected diseases is now at its highest ever level. Latest figures for 2017 show overall funding at $3.6bn—up 7% on 2016. It is the first time in eight years that funding has exceeded the previous high in 2009.
The report, funded by the Bill and Melinda Gates Foundation, covers diseases which disproportionately affect developing countries; …